BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 23632475)

  • 1. Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK.
    Storozhuk Y; Hopmans SN; Sanli T; Barron C; Tsiani E; Cutz JC; Pond G; Wright J; Singh G; Tsakiridis T
    Br J Cancer; 2013 May; 108(10):2021-32. PubMed ID: 23632475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic modulation of AMP-Kinase, Akt and mTOR pathways by ionizing radiation in human lung cancer xenografts.
    Storozhuk Y; Sanli T; Hopmans SN; Schultz C; Farrell T; Cutz JC; Steinberg GR; Wright J; Singh G; Tsakiridis T
    Radiat Oncol; 2012 May; 7():71. PubMed ID: 22607554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells.
    Sanli T; Rashid A; Liu C; Harding S; Bristow RG; Cutz JC; Singh G; Wright J; Tsakiridis T
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):221-9. PubMed ID: 20615625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin.
    Hung LVM; Moon JY; Ryu JY; Cho SK
    Phytomedicine; 2019 Oct; 63():153000. PubMed ID: 31280139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated.
    Park SY; Kim YM; Pyo H
    Mol Cancer; 2010 Aug; 9():222. PubMed ID: 20731837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest.
    Lundholm L; Hååg P; Zong D; Juntti T; Mörk B; Lewensohn R; Viktorsson K
    Cell Death Dis; 2013 Jan; 4(1):e478. PubMed ID: 23370278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition.
    Ding X; Cheng J; Pang Q; Wei X; Zhang X; Wang P; Yuan Z; Qian D
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):861-874. PubMed ID: 31419512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM/ATR and SMAD3 pathways contribute to 3-indole-induced G₁ arrest in cancer cells and xenograft models.
    Huang SM; Lu KT; Wang YC
    Anticancer Res; 2011 Jan; 31(1):203-8. PubMed ID: 21273599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CB11, a novel purine-based PPARɣ ligand, overcomes radio-resistance by regulating ATM signalling and EMT in human non-small-cell lung cancer cells.
    Kim TW; Hong DW; Park JW; Hong SH
    Br J Cancer; 2020 Dec; 123(12):1737-1748. PubMed ID: 32958825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizing radiation regulates the expression of AMP-activated protein kinase (AMPK) in epithelial cancer cells: modulation of cellular signals regulating cell cycle and survival.
    Sanli T; Storozhuk Y; Linher-Melville K; Bristow RG; Laderout K; Viollet B; Wright J; Singh G; Tsakiridis T
    Radiother Oncol; 2012 Mar; 102(3):459-65. PubMed ID: 22225791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
    Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
    J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin.
    Shi Y; Felley-Bosco E; Marti TM; Orlowski K; Pruschy M; Stahel RA
    BMC Cancer; 2012 Dec; 12():571. PubMed ID: 23211021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
    Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
    Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level.
    Chen S; Wang H; Ng WL; Curran WJ; Wang Y
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1524-9. PubMed ID: 22014955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice lacking protein phosphatase 5 are defective in ataxia telangiectasia mutated (ATM)-mediated cell cycle arrest.
    Yong W; Bao S; Chen H; Li D; Sánchez ER; Shou W
    J Biol Chem; 2007 May; 282(20):14690-4. PubMed ID: 17376776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
    Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP
    Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGFR Inhibition Enhances Sensitivity to Radiation in Non-Small Cell Lung Cancer.
    SenthilKumar G; Fisher MM; Skiba JH; Miller MC; Brennan SR; Kaushik S; Bradley ST; Longhurst CA; Buehler D; Nickel KP; Iyer G; Kimple RJ; Baschnagel AM
    Mol Cancer Ther; 2020 Jun; 19(6):1255-1265. PubMed ID: 32371583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mogrol-mediated enhancement of radiotherapy sensitivity in non-small cell lung cancer: a mechanistic study.
    Yin Z; Zhang X; Sun X; Huo Y; Ji N; Chen K
    Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1753-C1768. PubMed ID: 38682239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
    Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
    Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.